Tegoprazan dual and quadruple therapy for Helicobacter pylori eradication: a prospective, randomized controlled trial in Beijing, China
Authors
- Dongling Xie (ORCID: https://orcid.org/0000-0002-9689-8972)
- J. Cheng (ORCID: https://orcid.org/0000-0001-9196-1752)
- Xiaomei Zhang (ORCID: https://orcid.org/0000-0002-0510-6352)
- Zhen Li (ORCID: https://orcid.org/0000-0001-5524-895X)
- Haiou Ding
- Kun Huang (ORCID: https://orcid.org/0000-0002-3347-0688)
- Xiaolin Zhao (ORCID: https://orcid.org/0000-0002-7523-1511)
- Yong Cai (ORCID: https://orcid.org/0000-0002-1924-1731)
- Chanjuan Fan
- Lili Zhai
Institutions
- Chinese PLA General Hospital (CN)
- Aviation General Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.3389/fmed.2025.1629567
- Citations
- 1
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 2.01